If you’re looking for the biggest names in the pharmaceutical industry, here are the top 10 pharmaceutical companies in the US. They include Amgen, Lilly, Bristol-Myers Squibb, Takeda, and many more. Take a look at their revenues, market value, and more! These companies are responsible for a large portion of the United States’ health-care budget. In fact, they generate about half of all of that money.
Amgen is one of the leading biotech companies in the world, with a portfolio of drugs for various conditions. Its mission is to develop and deliver cost-effective therapeutics by harnessing the power of cellular biology and molecular biology to treat a wide range of medical conditions. The company believes that the discovery of new medicines is critical to improving health and human life. Its research and development focus is on new therapeutics for diseases such as cancer, Alzheimer’s, and Parkinson’s.
The company has a stellar track record of delivering innovative medicines. In recent years, Amgen has risen above its peers. The company was founded in 1980 and has numerous manufacturing sites around the US. Some of its biggest products include Neulasta, Prolia, and Vectibix. In addition, Amgen was one of the first biotech companies and has a portfolio of medicines for autoimmune disorders.
Founded in 1866, Eli Lilly has several uses in the US. It is one of the largest pharmaceutical companies in the world, with over five thousand employees. It was the first company to manufacture the Salk Polio Vaccine. After World War I, the company expanded and introduced new methods of management. It also created Humulin, a drug that is nearly identical to human insulin.
Aside from making many of the world’s most common medications, Lilly is also a world leader in the production of insulin and psychiatric medicines. The company devotes almost a quarter of its revenue to research and development. Its global footprint includes plants in thirteen different countries, and its products are sold in more than 120 nations. In the United States, the company’s revenue is around $21.2 billion.
Takeda Pharmaceuticals is one of the leading companies in the US, producing innovative medicines and delivering them to more than 100 countries. The company’s revenue fell 1% in 2019, but top sellers Entyvio and Takhzyro rose by over 24% and 30%, respectively. In contrast, sales at its Neuroscience and Rare Diseases segments decreased by 5% and 7%, respectively. CEO Keiichi Taniguchi said that the company is now focusing on developing new products.
The company grew quickly to become a global player in the pharmaceutical industry, acquiring several companies over the years. The company recently entered a joint venture with Abbott Laboratories for the development of Soticlestat, a drug for Lennox-Gastaut syndrome. In the first half of FY2021, Takeda plans to begin a Phase 3 study on Soticlestat. The drug is expected to enter the clinic by the second half of FY2021.
Bristol-Myers Squib is a leading pharmaceutical company in the United States. Founded in 1858 by Edward Robinson Squibb, the company has grown into one of the world’s largest and most diversified corporations. Last year, the company reported revenue of $19.4 billion, up 9% over the same period the previous year. Its strong sales were primarily attributed to its cancer drugs and anticoagulants. The company has a robust product development pipeline with a healthy outlook. As of June 2018, the company has received regulatory approval for twenty new drugs and medical devices.
The company manufactures a range of products, including prescription drugs and vaccines. It also manufactures infant formulas such as Enfamil. It also distributes pharmaceuticals for diabetes and hypertension. It has six sales offices and sells its products through pooled procurement in seven countries. A brief history of the company can be found here. This company is headquartered in New Jersey, between Princeton and West Windsor.
Pfizer is a diversified US pharmaceutical company with revenue of $51.8 billion in 2019. The company produces vaccines and medicines for various medical disciplines. Its products include diabetes medicines, anti-inflammatory drugs, and cardiovascular care products. Pfizer is headquartered in New York City. The company is ranked as the second largest pharmaceutical company in the US. As of Aug. 9, 2022, Pfizer’s market cap is $279.3 billion.
The company is among the top ten because it is a global leader in producing and delivering medicines. Despite these challenges, it is confident that the company will be able to deliver on its sales growth expectations. The company is still facing many headwinds, including increased competition in the field of vaccines. The top ten pharmaceutical companies face ongoing macroeconomic challenges, such as China’s disruption of global supply chains. Other major challenges faced by the industry include volatile M&A and seller valuation environments, as well as an impending “patent winter.” Analysts are predicting a period of branded sales erosion that is the most severe since the 1980s.